Posts Tagged ‘ Dysport ’

FDA Approves XEOMIN, a Type of Botulinum Toxin, for Cosmetic Use

Is the third time the charm?  This month the FDA approved Xeomin® (incobotulinumtoxinA) for the treatment of moderate to severe wrinkles in the glabellar region (frown lines).  This is the third botulinum toxin to be approved by the FDA for cosmetic use (following Botox and Dysport).  Merz Aesthetics plans to release Xeomin for use in the Spring […]


Dysport is Available!

The first real Botox competitor, Dysport, is finally reaching plastic surgeons’ offices here in the U.S. We received our first shipment this week and I’m excited to bring this product to my patients. Like Botox, it’s a Botulinum Toxin Type A and is FDA-approved to temporarily reducing the wrinkles in the glabella (frown lines). Doctors […]


FDA Approves Botox Competitor Dysport / Reloxin!

BIG news in the plastic surgery field. The FDA approved the drug Dysport (otherwise known as Reloxin) today for the treatment of fine lines in the glabella (between the brows). This is the first bona-fide competitor to Botox, as it is also a Botulinum Toxin Type A. I’ve mentioned Reloxin in this blog before, as […]